Products

f-star will apply its unique Modular Antibody Technology to develop its own proprietary pipeline of therapeutic product candidates. The company is in the process of evaluating a number of different product candidate concepts. f-star will focus on areas of high unmet medical need. The competitive advantage in a specific disease setting, a favourable development risk profile as well as freedom to operate for the chosen combination of target and format will be the key determinants in the decision which product candidate to take forward.